Matches in Wikidata for { <http://www.wikidata.org/entity/Q95933304> ?p ?o ?g. }
- Q95933304 description "2020 nî lūn-bûn" @default.
- Q95933304 description "2020年の論文" @default.
- Q95933304 description "2020年学术文章" @default.
- Q95933304 description "2020年学术文章" @default.
- Q95933304 description "2020年学术文章" @default.
- Q95933304 description "2020年学术文章" @default.
- Q95933304 description "2020年学术文章" @default.
- Q95933304 description "2020年学术文章" @default.
- Q95933304 description "2020年學術文章" @default.
- Q95933304 description "2020年學術文章" @default.
- Q95933304 description "2020年學術文章" @default.
- Q95933304 description "2020年學術文章" @default.
- Q95933304 description "2020年學術文章" @default.
- Q95933304 description "2020년 논문" @default.
- Q95933304 description "article científic" @default.
- Q95933304 description "article scientific" @default.
- Q95933304 description "article scientifique" @default.
- Q95933304 description "articol științific" @default.
- Q95933304 description "articolo scientifico" @default.
- Q95933304 description "artigo científico" @default.
- Q95933304 description "artigo científico" @default.
- Q95933304 description "artigo científico" @default.
- Q95933304 description "artikel ilmiah" @default.
- Q95933304 description "artikull shkencor" @default.
- Q95933304 description "artikulong pang-agham" @default.
- Q95933304 description "artykuł naukowy" @default.
- Q95933304 description "artículo científico publicado en 2020" @default.
- Q95933304 description "artículu científicu" @default.
- Q95933304 description "bilimsel makale" @default.
- Q95933304 description "bài báo khoa học" @default.
- Q95933304 description "naučni članak" @default.
- Q95933304 description "scienca artikolo" @default.
- Q95933304 description "scientific article published on 28 May 2020" @default.
- Q95933304 description "scientific article published on 28 May 2020" @default.
- Q95933304 description "scientific article published on 28 May 2020" @default.
- Q95933304 description "teaduslik artikkel" @default.
- Q95933304 description "tieteellinen artikkeli" @default.
- Q95933304 description "tudományos cikk" @default.
- Q95933304 description "vedecký článok" @default.
- Q95933304 description "vetenskaplig artikel" @default.
- Q95933304 description "videnskabelig artikel udgivet 28. maj 2020" @default.
- Q95933304 description "vitenskapelig artikkel" @default.
- Q95933304 description "vitskapeleg artikkel" @default.
- Q95933304 description "vědecký článek" @default.
- Q95933304 description "wetenschappelijk artikel" @default.
- Q95933304 description "wissenschaftlicher Artikel" @default.
- Q95933304 description "επιστημονικό άρθρο" @default.
- Q95933304 description "мақолаи илмӣ" @default.
- Q95933304 description "наукова стаття, опублікована в травні 2020" @default.
- Q95933304 description "научна статия" @default.
- Q95933304 description "научная статья" @default.
- Q95933304 description "научни чланак" @default.
- Q95933304 description "научни чланак" @default.
- Q95933304 description "מאמר מדעי" @default.
- Q95933304 description "مقالة علمية نشرت في 28 مايو 2020" @default.
- Q95933304 description "২৮ মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q95933304 description "บทความทางวิทยาศาสตร์" @default.
- Q95933304 description "სამეცნიერო სტატია" @default.
- Q95933304 name "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 name "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 type Item @default.
- Q95933304 label "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 label "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 prefLabel "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 prefLabel "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 P1433 Q95933304-65F9A163-D1C3-4CD6-B13D-3E4B191E9D55 @default.
- Q95933304 P1476 Q95933304-6B10AF2A-8601-4F40-86DF-EE28E5E7D6B6 @default.
- Q95933304 P2093 Q95933304-08B2DB1F-A750-42E4-90B1-DA9B4206C484 @default.
- Q95933304 P2093 Q95933304-0AAE3A01-62C0-4A27-B737-9E27E4BBB2A0 @default.
- Q95933304 P2093 Q95933304-10B94CF2-4C57-439B-8E3D-ED51EC75DDF0 @default.
- Q95933304 P2093 Q95933304-337F3016-5B09-401B-B60B-C8438B4EA89B @default.
- Q95933304 P2093 Q95933304-40D1DE84-6735-49CA-A497-F3A84F4DDBCF @default.
- Q95933304 P2093 Q95933304-557E836D-6A8E-45FB-8106-1202482FBB63 @default.
- Q95933304 P2093 Q95933304-6904AB58-7BE3-43DA-B969-AF3D37437E96 @default.
- Q95933304 P2093 Q95933304-7DB138BE-7CFE-4B75-B2A3-A86FC010C654 @default.
- Q95933304 P2093 Q95933304-9C49E31D-6F7A-4C7F-B2B1-128FCA5BBEB5 @default.
- Q95933304 P2093 Q95933304-BC8C612A-49CE-45F5-8B46-CF6BA143CEEB @default.
- Q95933304 P2093 Q95933304-BE1A7AAE-00EA-4C5A-8E45-61A3918A61BE @default.
- Q95933304 P2093 Q95933304-CAA8F3DB-FE03-4FC4-898B-3DCD362831CF @default.
- Q95933304 P2093 Q95933304-CD02B742-C012-4BB0-868E-1D2170C9ADBE @default.
- Q95933304 P2093 Q95933304-CD524816-19DB-4C72-8680-CDB10037A9EC @default.
- Q95933304 P2093 Q95933304-E19492FC-00C2-4360-A5FB-F72B3DC61E65 @default.
- Q95933304 P2093 Q95933304-EA2F3947-3744-4DAE-AA08-5F51E1DF97D7 @default.
- Q95933304 P2093 Q95933304-EB8762F1-331A-4420-99E1-90CAB30A60CF @default.
- Q95933304 P2093 Q95933304-FEF2091B-FA1F-428F-B6C5-F96F6F0A8F10 @default.
- Q95933304 P304 Q95933304-91CA499D-8A67-4A6C-8A6D-D869A5A93771 @default.
- Q95933304 P31 Q95933304-8AB5F479-667A-4F6A-A3D0-D4E8A89728C3 @default.
- Q95933304 P356 Q95933304-EDCA287D-6DFE-4C56-B26B-1C56BDE2D9DC @default.
- Q95933304 P433 Q95933304-DD02ED11-4840-4313-9BA5-762CA1CD5064 @default.
- Q95933304 P478 Q95933304-7E59F917-565D-47D5-B0A5-1EE0B8030C1A @default.
- Q95933304 P50 Q95933304-4AE36EA8-9034-417A-B534-E7B4B761C94A @default.
- Q95933304 P577 Q95933304-5B959213-ECA9-44F6-9A15-9224443E458A @default.
- Q95933304 P698 Q95933304-B6723B56-95DC-41E9-AAF7-5B1636AB50EE @default.
- Q95933304 P921 Q95933304-2D943447-9D87-45CA-86DA-4F536737157F @default.
- Q95933304 P932 Q95933304-00D63D93-F774-47EE-9FA2-5171F518822A @default.
- Q95933304 P356 S13058-020-01290-X @default.
- Q95933304 P698 32466779 @default.
- Q95933304 P1433 Q2208481 @default.
- Q95933304 P1476 "Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer" @default.
- Q95933304 P2093 "Anne Perdrix" @default.